data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Novo Nordisk
(NYSE:NVO)
$111.64
0.21[0.19%]
At close: Jul 1
$111.64
00
After Hours: 4:00PM EDT
Day High/Low108.71 - 111.85
52 Week High/Low83.86 - 122.16
Open / Close109.73 / 111.64
Float / Outstanding- / 2.3B
Vol / Avg.934.6K / 1.5M
Mkt Cap252.8B
P/E36.97
50d Avg. Price109.36
Div / Yield1.57/1.41%
Payout Ratio47.8
EPS6.24
Total Float-

Novo Nordisk (NYSE:NVO), Quotes and News Summary

Novo Nordisk (NYSE: NVO)

Day High/Low108.71 - 111.85
52 Week High/Low83.86 - 122.16
Open / Close109.73 / 111.64
Float / Outstanding- / 2.3B
Vol / Avg.934.6K / 1.5M
Mkt Cap252.8B
P/E36.97
50d Avg. Price109.36
Div / Yield1.57/1.41%
Payout Ratio47.8
EPS6.24
Total Float-
Benzinga - 5 days ago
Benzinga - 6 days ago
Benzinga - 6 days ago
Benzinga - Jun 7, 2022, 10:38AM
Benzinga - Jun 7, 2022, 10:32AM
Benzinga - Jun 7, 2022, 7:15AM
Benzinga - Jun 7, 2022, 5:01AM
Benzinga - Jun 3, 2022, 5:01AM
Benzinga - May 31, 2022, 12:37PM
Benzinga - May 31, 2022, 8:09AM
Benzinga - Apr 29, 2022, 5:09AM
Benzinga - Apr 29, 2022, 5:05AM
Benzinga - Apr 28, 2022, 2:44PM
Benzinga - Apr 28, 2022, 10:55AM
Benzinga - Apr 27, 2022, 10:26AM
load more
Sector: Health Care.Industry: Pharmaceuticals
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS0.8000.940 0.1400
REV5.590B6.341B751.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Novo Nordisk Questions & Answers

Q
How do I buy Novo Nordisk (NVO) stock?
A

You can purchase shares of Novo Nordisk (NYSE: NVO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Novo Nordisk's (NVO) competitors?
Q
What is the target price for Novo Nordisk (NVO) stock?
A

The latest price target for Novo Nordisk (NYSE: NVO) was reported by UBS on Tuesday, June 28, 2022. The analyst firm set a price target for 0.00 expecting NVO to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Novo Nordisk (NVO)?
A

The stock price for Novo Nordisk (NYSE: NVO) is $111.64 last updated July 1, 2022, 7:59 PM UTC.

Q
Does Novo Nordisk (NVO) pay a dividend?
A

A quarterly cash dividend of $1.04 per share of Class A Common Stock. The quarterly cash dividend was payable on April 5, 2022 to stockholders of record on March 25, 2022.

Q
When is Novo Nordisk (NYSE:NVO) reporting earnings?
A

Novo Nordisk’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Novo Nordisk (NVO) going to split?
A

There is no upcoming split for Novo Nordisk.

Q
What sector and industry does Novo Nordisk (NVO) operate in?
A

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.